AstraZeneca says its Covid-19 vaccine is 79 percent effective at preventing the disease and does not increase the risk of blood clots, following US phase III trials AstraZeneca’s Covid-19 vaccine is 80 percent effective at preventing the disease in the elderly and does not increase the risk of blood clots, the biotech firm said Monday,...